These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8044777)

  • 1. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation.
    Koi M; Umar A; Chauhan DP; Cherian SP; Carethers JM; Kunkel TA; Boland CR
    Cancer Res; 1994 Aug; 54(16):4308-12. PubMed ID: 8044777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.
    Hawn MT; Umar A; Carethers JM; Marra G; Kunkel TA; Boland CR; Koi M
    Cancer Res; 1995 Sep; 55(17):3721-5. PubMed ID: 7641183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.
    Umar A; Koi M; Risinger JI; Glaab WE; Tindall KR; Kolodner RD; Boland CR; Barrett JC; Kunkel TA
    Cancer Res; 1997 Sep; 57(18):3949-55. PubMed ID: 9307278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.
    Vikhanskaya F; Colella G; Valenti M; Parodi S; D'Incalci M; Broggini M
    Clin Cancer Res; 1999 Apr; 5(4):937-41. PubMed ID: 10213232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.
    Carethers JM; Hawn MT; Chauhan DP; Luce MC; Marra G; Koi M; Boland CR
    J Clin Invest; 1996 Jul; 98(1):199-206. PubMed ID: 8690794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectra of spontaneous mutations at the hprt locus in colorectal carcinoma cell lines defective in mismatch repair.
    Ohzeki S; Tachibana A; Tatsumi K; Kato T
    Carcinogenesis; 1997 Jun; 18(6):1127-33. PubMed ID: 9214593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence or decreased levels of the hMLH1 protein in human gastric carcinoma cell lines: implication of hMLH1 in alkylation tolerance.
    Shin KH; Yang YM; Park JG
    J Cancer Res Clin Oncol; 1998; 124(8):421-6. PubMed ID: 9750018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity.
    Risinger JI; Umar A; Boyer JC; Evans AC; Berchuck A; Kunkel TA; Barrett JC
    Cancer Res; 1995 Dec; 55(23):5664-9. PubMed ID: 7585651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1.
    Shin KH; Park JG
    Eur J Cancer; 2000 May; 36(7):925-31. PubMed ID: 10785599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of DNA mismatch repair in acquired resistance to cisplatin.
    Aebi S; Kurdi-Haidar B; Gordon R; Cenni B; Zheng H; Fink D; Christen RD; Boland CR; Koi M; Fishel R; Howell SB
    Cancer Res; 1996 Jul; 56(13):3087-90. PubMed ID: 8674066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15.
    Lettieri T; Marra G; Aquilina G; Bignami M; Crompton NE; Palombo F; Jiricny J
    Carcinogenesis; 1999 Mar; 20(3):373-82. PubMed ID: 10190549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1.
    Cejka P; Stojic L; Mojas N; Russell AM; Heinimann K; Cannavó E; di Pietro M; Marra G; Jiricny J
    EMBO J; 2003 May; 22(9):2245-54. PubMed ID: 12727890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents.
    Colella G; Marchini S; D'Incalci M; Brown R; Broggini M
    Br J Cancer; 1999 May; 80(3-4):338-43. PubMed ID: 10408835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA mismatch repair mutants do not increase N-methyl-N'-nitro-N-nitrosoguanidine tolerance in O6-methylguanine DNA methyltransferase-deficient yeast cells.
    Xiao W; Rathgeber L; Fontanie T; Bawa S
    Carcinogenesis; 1995 Aug; 16(8):1933-9. PubMed ID: 7634424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased somatic recombination in methylation tolerant human cells with defective DNA mismatch repair.
    Ciotta C; Ceccotti S; Aquilina G; Humbert O; Palombo F; Jiricny J; Bignami M
    J Mol Biol; 1998 Mar; 276(4):705-19. PubMed ID: 9500919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer.
    Watanabe Y; Haugen-Strano A; Umar A; Yamada K; Hemmi H; Kikuchi Y; Takano S; Shibata Y; Barrett JC; Kunkel TA; Koi M
    Mol Carcinog; 2000 Sep; 29(1):37-49. PubMed ID: 11020245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma.
    Alvino E; Marra G; Pagani E; Falcinelli S; Pepponi R; Perrera C; Haider R; Castiglia D; Ferranti G; Bonmassar E; Jiricny J; Zambruno G; D'Atri S
    J Invest Dermatol; 2002 Jan; 118(1):79-86. PubMed ID: 11851879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability.
    Ma AH; Xia L; Littman SJ; Swinler S; Lader G; Polinkovsky A; Olechnowicz J; Kasturi L; Lutterbaugh J; Modrich P; Veigl ML; Markowitz SD; Sedwick WD
    Oncogene; 2000 Apr; 19(18):2249-56. PubMed ID: 10822375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense inhibition of hMLH1 is not sufficient for loss of DNA mismatch repair function in the HCT116+chromosome 3 cell line.
    Chauhan DP; Yang Q; Carethers JM; Marra G; Chang CL; Chamberlain SM; Boland CR
    Clin Cancer Res; 2000 Oct; 6(10):3827-31. PubMed ID: 11051225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
    Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M
    Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.